American Portfolios Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $786K | Buy |
9,906
+2,584
| +35% | +$205K | 0.03% | 496 |
|
|
2022
Q2 | $544K | Buy |
7,322
+2,839
| +63% | +$211K | 0.02% | 625 |
|
|
2022
Q1 | $403K | Sell |
4,483
-1,633
| -27% | -$147K | 0.01% | 841 |
|
|
2021
Q4 | $685K | Sell |
6,116
-75
| -1% | -$8.4K | 0.02% | 616 |
|
|
2021
Q3 | $778K | Buy |
6,191
+421
| +7% | +$52.9K | 0.03% | 541 |
|
|
2021
Q2 | $781K | Buy |
5,770
+285
| +5% | +$38.6K | 0.03% | 538 |
|
|
2021
Q1 | $744K | Buy |
5,485
+45
| +0.8% | +$6.1K | 0.03% | 506 |
|
|
2020
Q4 | $766K | Buy |
5,440
+128
| +2% | +$18K | 0.04% | 423 |
|
|
2020
Q3 | $592K | Sell |
5,312
-198
| -4% | -$22.1K | 0.03% | 432 |
|
|
2020
Q2 | $617K | Buy |
5,510
+185
| +3% | +$20.7K | 0.04% | 381 |
|
|
2020
Q1 | $412K | Sell |
5,325
-3
| -0.1% | -$232 | 0.03% | 418 |
|
|
2019
Q4 | $507K | Buy |
5,328
+220
| +4% | +$20.9K | 0.04% | 411 |
|
|
2019
Q3 | $389K | Buy |
5,108
+300
| +6% | +$22.9K | 0.03% | 477 |
|
|
2019
Q2 | $422K | Sell |
4,808
-1,690
| -26% | -$148K | 0.04% | 449 |
|
|
2019
Q1 | $588K | Buy |
6,498
+595
| +10% | +$53.9K | 0.06% | 326 |
|
|
2018
Q4 | $424K | Buy |
5,903
+4,162
| +239% | +$299K | 0.05% | 315 |
|
|
2018
Q3 | $167K | Buy |
1,741
+148
| +9% | +$14.2K | 0.02% | 650 |
|
|
2018
Q2 | $152K | Sell |
1,593
-1,041
| -40% | -$99.1K | 0.02% | 665 |
|
|
2018
Q1 | $231K | Sell |
2,634
-2,093
| -44% | -$184K | 0.03% | 455 |
|
|
2017
Q4 | $401K | Buy |
+4,727
| New | +$401K | 0.06% | 307 |
|